Global X CleanTech vs Heron Therapeutics Inc — how do they compare? Global X CleanTech trades at $55.45 (market cap $24.57M), while Heron Therapeutics Inc trades at $0.4 (market cap $68.01M). The key difference: Heron Therapeutics Inc is far larger — about 2.8× Global X CleanTech's market cap, and Heron Therapeutics Inc is more actively traded (1,891,941 versus 1,220). Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and Heron Therapeutics Inc for 35 Days on average.
| CTEC | HRTX | |
|---|---|---|
Market Cap | $24.57M | $68.01M |
Volume | 1,220 | 1,891,941 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $1.49 |
52-Week Low | $50.82 | $0.27 |
Typical Hold Time | 42 Days | 35 Days |
Enterprise Value | — | $174.75M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) trades at $0.39, up 0.95% with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings discussions.
The outlook remains challenged by persistent losses and negative margins, though strong analyst support suggests potential upside. Key risks include execution on sales targets and achieving profitability. The stock's low price near 52-week lows presents speculative opportunity but requires careful risk management given financial performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →